[144] Arbe Robotics Ltd. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for ARBEW shows an intended sale of 87,842 ordinary shares on or about 09/19/2025 through Raymond James & Associates on NASDAQ, with an aggregate market value of $147,574.56. The filing reports that these shares were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Inc for cash, and that the filer previously sold 100,000 ordinary shares on 09/18/2025 (gross proceeds $147,684.05) by Canaan Partners Israel. The issuer outstanding share count is listed as 105,163,188. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive

• Disclosure compliance: Form 144 provides required details (broker, shares, acquisition info) enabling transparent resale under Rule 144
• Small relative size: 87,842 shares represent a very small fraction of 105,163,188 outstanding shares

Negative

• Recent insider selling: A prior sale of 100,000 shares on 09/18/2025 is disclosed, indicating continued insider-affiliated sales activity
• Filer identity incomplete in provided text: Submission contact and filer identifiers are not specified in the extracted content

Insights

Securities Analyst

TL;DR: Insider-related sale notice for 87,842 shares valued at about $147.6k, sourced from a 2016 private placement.

The Form 144 is a routine compliance filing that notifies the market of an upcoming sale by an affiliate or control person under Rule 144. The quantities and values disclosed are modest relative to the reported outstanding shares (87,842 versus 105,163,188 outstanding). The filing confirms acquisition provenance (private placement 03/30/2016) and prior recent sale activity (100,000 shares on 09/18/2025). This document does not provide operational or financial performance data; its primary relevance is disclosure of potential share supply entering the market and compliance with resale rules.

Compliance / Corporate Governance Expert

TL;DR: The filing meets Rule 144 disclosure elements and includes the required signer representation.

The notice contains required elements: broker identity, number of shares, market value, acquisition date and nature, and recent sales by an affiliated party. It also includes the statutory representation regarding undisclosed material adverse information. Filer identification fields appear incomplete in the provided text, but key transaction fields are present. This is a procedural disclosure rather than material operational news.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	87842	147574.56	105163188	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	03/30/2016	Private Placement	Arbe Robotics Inc			4261734	03/30/2016	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Canaan Partners Israel (CPI) 47 Yehuda Hanasi St. Apt 83, Tel Aviv L3 6939109	Ordinary	09/18/2025	100000	147684.05

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ARBEW Form 144 disclose about the planned sale?

The notice discloses an intended sale of 87,842 ordinary shares on or about 09/19/2025 through Raymond James & Associates with aggregate market value $147,574.56.

When and how were the shares being sold acquired?

The shares were acquired in a private placement on 03/30/2016 from Arbe Robotics Inc, with payment in cash.

Has any related sale occurred recently for ARBEW insiders?

Yes. The filing lists a sale of 100,000 ordinary shares on 09/18/2025 by Canaan Partners Israel with gross proceeds of $147,684.05.

How many shares outstanding does the filing report?

The document reports 105,163,188 shares outstanding for the issuer.

Through which broker will the shares be sold and on which exchange?

The sale is to be executed via Raymond James & Associates and is listed for NASDAQ.